Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · IEX Real-Time Price · USD
28.34
-0.07 (-0.25%)
Apr 26, 2024, 4:00 PM EDT - Market closed

IART Revenue

In the year 2023, Integra LifeSciences Holdings had annual revenue of $1.54B, a decrease of -1.03%. Revenue in the quarter ending December 31, 2023 was $397.04M, a -0.25% decrease year-over-year.

Revenue (ttm)
$1.54B
Revenue Growth
-1.03%
P/S Ratio
1.44
Revenue / Employee
$390,667
Employees
3,946
Market Cap
2.22B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.54B-16.09M-1.03%
Dec 31, 20221.56B15.22M0.99%
Dec 31, 20211.54B170.58M12.43%
Dec 31, 20201.37B-145.69M-9.60%
Dec 31, 20191.52B45.12M3.06%
Dec 31, 20181.47B284.21M23.92%
Dec 31, 20171.19B196.16M19.77%
Dec 31, 2016992.08M109.34M12.39%
Dec 31, 2015882.73M86.02M10.80%
Dec 31, 2014796.72M99.89M14.33%
Dec 31, 2013696.83M-134.04M-16.13%
Dec 31, 2012830.87M50.79M6.51%
Dec 31, 2011780.08M48.01M6.56%
Dec 31, 2010732.07M49.58M7.26%
Dec 31, 2009682.49M27.88M4.26%
Dec 31, 2008654.60M104.15M18.92%
Dec 31, 2007550.46M131.16M31.28%
Dec 31, 2006419.30M141.36M50.86%
Dec 31, 2005277.94M48.11M20.93%
Dec 31, 2004229.83M44.23M23.83%
Dec 31, 2003185.60M67.78M57.52%
Dec 31, 2002117.82M24.38M26.09%
Dec 31, 200193.44M21.79M30.42%
Dec 31, 200071.65M28.77M67.11%
Dec 31, 199942.88M25.32M144.15%
Dec 31, 199817.56M2.82M19.09%
Dec 31, 199714.75M1.60M12.15%
Dec 31, 199613.15M2.92M28.54%
Dec 31, 199510.23M1.57M18.10%
Dec 31, 19948.66M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teladoc Health 2.60B
ICU Medical 2.26B
Privia Health Group 1.66B
Tandem Diabetes Care 747.72M
Inari Medical 493.63M
STAAR Surgical Company 322.42M
TG Therapeutics 233.66M
Vericel 197.52M
Revenue Rankings